Natural Chlamydia trachomatis Immunity Highlights CPAF as a Key Vaccine Target 2258359
The Journal of Immunology · 01.08.2026 · 215 (Supplement_1)
DOI: 10.1093/jimmun/vkag141.577 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 28.07.2026. Verfasst von Toni Darville und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Our previous studies identified Chlamydia trachomatis (CT)-specific IFNg-producing CD4+ T cells as correlates of protection from reinfection, whereas higher antibody titers marked exposure, and CPAF (CT858) emerged as an immunodominant T cell target.
Methods
We analyzed IFNg ELISPOT responses to seven CT antigens (CT005, CT372, CT486, CT529, CT681, CT858, CT871) in 79 women stratified as FU- (n = 48), who completed ≥3 of 4 follow-up visits and remained CT-negative, or FU + (n=31), who tested CT-positive at any visit within one year. Frequencies of positive responders and summed antigen responses were compared using Fisher’s exact or Chi-squared tests. Correlations between total antigen-specific IFNg responses and anti-CT IgG titers were assessed by Spearman analysis, and Wilcoxon tests compared response magnitudes by antibody titer (≤1:64 vs > 1:64). Antigen-specific antibody levels (CT529, CT681, CT858) were correlated with corresponding T cell responses, and CPAF-specific responses were further analyzed by anti-CPAF antibody levels (< 45% vs ≥ 45%).
Results
IFNg responses were most frequent to CT858 (n = 34) and CT529 (n = 34), followed by CT005 (n = 22), CT486 (n = 16), CT681 (n = 11), CT871 (n = 6), and CT372 (n = 4). Response frequencies and magnitudes did not differ between FU- and FU+ groups. In FU+ participants, IFNg responses correlated with anti-CT IgG titers (Rho=0.4, P = 0.03), a pattern not observed in FU- women. Among women with low anti-CT IgG titers, higher IFNg responses were detected in FU- compared with FU+ groups (P = 0.03), whereas no difference was seen among those with high titers. Among women with low anti-CPAF IgG, higher CPAF-specific IFNg responses showed a trend toward protection from reinfection (P = 0.19 for FU- vs FU+).
Conclusion
These findings indicate that natural infection elicits CT-specific IFNg T cell responses, yet reinfection still occurs. Stronger T cell responses, particularly to CPAF, were linked to lower reinfection risk, supporting CPAF as a key target for CT vaccine design. Funding Source NIAID U19AI144181, T32AI007001, American Association of Immunologists Intersect Fellowship Program for Computational Scientists and Immunologists Topic Categories Vaccines and Immunotherapy (VAC)
Zitieren
APA
Darville, T., Shaw, F., Sun, X., Yount, K., Li, Y., O’Connell, C., Warren, J., & Goonetilleke, N. (2026). Natural Chlamydia trachomatis Immunity Highlights CPAF as a Key Vaccine Target 2258359. The Journal of Immunology, 215(Supplement_1). https://doi.org/10.1093/jimmun/vkag141.577
Vancouver
Darville T, Shaw F, Sun X, Yount K, Li Y, O’Connell C, et al. Natural Chlamydia trachomatis Immunity Highlights CPAF as a Key Vaccine Target 2258359. The Journal of Immunology. 2026;215(Supplement_1). doi:10.1093/jimmun/vkag141.577
BibTeX
@article{Darville2026,
author = {Darville, Toni and Shaw, Fiona and Sun, Xuejun and Yount, Kacy and Li, Yanli and O’Connell, Catherine and Warren, Joanna and Goonetilleke, Nilu},
title = {Natural Chlamydia trachomatis Immunity Highlights CPAF as a Key Vaccine Target 2258359},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {Supplement_1},
doi = {10.1093/jimmun/vkag141.577}
}
EUVIMED